Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Baricitinib is an effective treatment for severe alopecia areata.

Gefitinib can cause scalp skin issues and permanent hair loss.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Pantethine may boost the immune system's ability to fight sarcoma.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ruxolitinib helped a man regrow his beard after years of hair loss.